Luo v. Spectrum Pharmaceuticals, Inc.

District Court, D. Nevada·Decided May 22, 2025·No. 2:21-cv-01612·Unknown

Opinion

1 2 UNITED STATES DISTRICT COURT 3 DISTRICT OF NEVADA

4] Jose Chung Luo, et al., Case No. 2:21-cv-001612-CDS-BNW 5 Plaintiffs Order Setting Hearing on Motion for Preliminary Approval of Proposed GI] v. Class Action Settlement 7|| Spectrum Pharmaceuticals, Inc., et al, [ECF No. 130] 8 Defendants 9 10 Lead plaintiff International Trading Group, Inc. filed an unopposed motion for preliminary approval of settlement. ECF No. 130. Under Federal Rule of Civil Procedure 23, if a 12|| proposal would bind class members, “the court may approve it only after a hearing and only on 13}| finding that it is fair, reasonable, and adequate after considering” a number of factors. Fed. R. 14]| Civ. P. 23(e)(2). Generally, the approval of class action settlements under Rule 23(e) occurs in 15|| two stages. In the first stage, “the court preliminarily approves the settlement pending a fairness 16|| hearing, temporarily certifies a settlement class, and authorizes notice to the class.” Ontiveros v. Zamora, 2014 WL 3057506, at *2 (E.D. Cal. July 7, 2014). Because that phase focuses on assessing 18|| whether the proposed settlement merits preliminary approval, which would lay the groundwork 19]| for a future fairness hearing, the parties are ordered to appear for a hearing on plaintiffs’ unopposed motion for preliminary approval of settlement on June 11, 2025, at 10:00 a.m. in LV Courtroom 6B. / 22 Dated: May 22, 2025 Jf 23 f Uy é 4 —— Crisfing’D. Silva 24 U ited States District Judge 25 l

Free access — add to your briefcase to read the full text and ask questions with AI

Luo v. Spectrum Pharmaceuticals, Inc., (D. Nev. 2025).

Luo v. Spectrum Pharmaceuticals, Inc. (Luo v. Spectrum Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.